Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2025-12-25 @ 1:43 AM
NCT ID:
NCT00413894
Eligibility Criteria:
Inclusion Criteria:
* adult patients, \>=18 years of age;
* chronic renal anemia;
* longterm hemodialysis for \>=12 weeks before screening;
* baseline Hb between 10 and 13g/dL;
* iv or sc maintenance epoetin alfa or beta or darbepoetin alfa therapy with same dosing interval for \>=4 weeks before screening.
Exclusion Criteria:
* acute or chronic bleeding within 8 weeks prior to screening;
* transfusion of red blood cells within 8 weeks prior to screening;
* poorly controlled hypertension necessitating interruption of erythropoetin treatment in previous 6 months;
* previous treatment with Mircera.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00413894
Study Brief:
Protocol Section:
NCT00413894